antibodies against ciap1 (Cell Signaling Technology Inc)

Cell Signaling Technology Inc is a verified supplier

Cell Signaling Technology Inc manufactures this product

About

News

Press Release

Team

Advisors

Partners

Contact

Bioz Stars

Bioz vStars

Buy from Supplier

Structured Review

Cell Signaling Technology Inc antibodies against ciap1
Antibodies Against Ciap1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ciap1/pm41587214-308-6-3
Average 86 stars, based on 1 article reviews

antibodies against ciap1 - by Bioz Stars, 2026-10

86/100 stars

Images

Western Blot:

Article Title: Epstein-Barr Virus Latent Membrane Protein 1 targets cIAP1, cIAP2 and TRAF2 for Proteasomal Degradation to Activate the Non-canonical NF-κB Pathway
Article Snippet: .. For immunoblot analysis, Cell Signaling Technology antibodies against cIAP1 (D5G9), cIAP2 (58C7), XIAP (3B6), TRAF1 (45D3), TRAF3 (#4729), TRAF5 (#D3E2R), FLAG (M2, #2368), V5 (#D3H8Q), NIK (#4994) and ubiquitin (P4D1, #3936) were used at 1:1000 for immunoblot analysis. .. Antibodies against TRAF2 (Proteintech 26846-1-AP), TRAF2 (Invitrogen SD205-06), HA (Abcam ab9110), and p100/52 (EMD Millipore #05-361) were used at 1:1000.

Article Title: Epstein-barr virus latent membrane protein 1 targets cIAP1, cIAP2 and TRAF2 for proteasomal degradation to activate the non-canonical NF-κB pathway
Article Snippet: .. For immunoblot analysis, Cell Signaling Technology antibodies against cIAP1 (D5G9), cIAP2 (58C7), XIAP (3B6), TRAF1 (45D3), TRAF3 (#4729), TRAF5 (#D3E2R), FLAG (M2, #2368), V5 (#D3H8Q), NIK (#4994) and ubiquitin (P4D1, #3936) were used at 1:1000 for immunoblot analysis. .. Antibodies against TRAF2 (Proteintech 26846–1-AP), TRAF2 (Invitrogen SD205–06), HA (Abcam ab9110), and p100/52 (EMD Millipore #05–361) were used at 1:1000.

Article Title: Epstein-barr virus latent membrane protein 1 targets cIAP1, cIAP2 and TRAF2 for proteasomal degradation to activate the non-canonical NF-κB pathway.
Article Snippet: .. For immunoblot analysis, Cell Signaling Technology antibodies against cIAP1 (D5G9), cIAP2 (58C7), XIAP (3B6), TRAF1 (45D3), TRAF3 (#4729), TRAF5 (#D3E2R), FLAG (M2, #2368), V5 (#D3H8Q), NIK (#4994) and ubiquitin (P4D1, #3936) were used at 1:1000 for immunoblot analysis. .. Antibodies against TRAF2 (Proteintech 26846–1-AP), TRAF2 (Invitrogen SD205–06), HA (Abcam ab9110), and p100/52 (EMD Millipore #05–361) were used at 1:1000.

Ubiquitin Proteomics:

other:

Article Title: Proteomic Analysis of Hsp90β-selective Inhibitors Against Triple-negative Breast Cancer (TNBC) to Gain a Mechanistic Insight.
Article Snippet: The blots were developed using Clarity Max Western ECL Blotting Substrates (Bio-Rad).

Cell-Signaling:

Article Title: Proteomic Analysis of Hsp90β-Selective Inhibitors Against Triple-Negative Breast Cancer to Gain a Mechanistic Insight
Article Snippet: The blots were developed using Clarity Max Western ECL Blotting Substrates (Bio-Rad). .. The following primary antibodies were obtained from Cell Signaling Technology: CXCR4 (D4Z7W), cIAP-1 (D5G9), Akt (9272), β-Actin (8H10D10), P53 (7F5), CDK4 (D9G3E), CDK6 (DCS83), and Survivin (71G4B7). .. The following primary antibodies were obtained from Enzo Life Sciences: Hsp70/Hsp72 (C92F3A-5) and Hsp90α (9D2).

Review